To provide additional evidence for the ability of cEVs or pEVs to mitigate renal damage in an AKI model, we assessed the levels of markers of kidney injury, including kidney injury molecule-1 (Kim1) and neutrophil gelatinase-associated lipocalin (Ngal). The gene discussed is LCN2; the disease is urogenital neoplasm.